Send to

Choose Destination
Pediatrics. 2001 Dec;108(6):1370-3.

Fatty acids, alpha-fetoprotein, and cystic fibrosis.

Author information

Division of Molecular Medicine, Wadsworth Center, Department of Health, Albany, NY 12201, USA.


Docosahexaenoic acid, found lacking in animal models of cystic fibrosis, has been proposed as a dietary supplement therapy for this genetic disorder. Alpha-fetoprotein, which binds and transports docosahexaenoic acid, may be a useful marker to improve the management and follow-up in newborn screening programs for cystic fibrosis, because only 20% of such infants are diagnosed at birth.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center